您的位置: 首页 > 农业专利 > 详情页

azaindazole compounds as ccr1 receptor antagonists
专利权人:
Boehringer Ingelheim International Gmbh
发明人:
Alan David Swinamer,Brian Christopher Raudenbush,Brian Nicholas Cook,Can Mao,Christian Harcken,Daniel Kuzmich,Daniel Robert Fandrick,Darren Disalvo,Hossein Razavi,Jinhua J. Song,Jochen Neu,John Lord,J
申请号:
BRPI0919844
公开号:
BRPI0919844A2
申请日:
2009.09.22
申请国别(地区):
BR
年份:
2019
代理人:
摘要:
Disclosed are compounds of the formula (I), useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of CCR1 including autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. Also disclosed are methods of making and methods of using same.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充